Ashwagandha, a herb traditionally used in Indian and Middle Eastern medicine, has become increasingly popular in the UK over the last decade. This surge in popularity is largely due to claims that the herb can alleviate anxiety and enhance sleep quality. Among its high-profile users are celebrities such as Gwyneth Paltrow, Jennifer Lopez, and Meghan Markle.
The supplement is commonly available in various forms, including tablets, gummies, and water-soluble powders, often promoted by social media influencers on platforms like TikTok and Instagram. However, recent developments have prompted the Food Standards Agency (FSA) to initiate an investigation into the safety of ashwagandha consumption.
The FSA has expressed concerns about the lack of established safe levels for ashwagandha in supplements within the UK. The agency has highlighted potential links between the herb and thyroid toxicity, as well as possible liver toxicity. Additionally, ashwagandha may affect thyroid hormone levels and exhibit hypoglycaemic effects, potentially leading to drops in blood sugar levels.
In response to these concerns, the FSA has called upon experts and companies involved in the production and sale of ashwagandha to provide evidence regarding the supplement's safety.
Elizabeth Montgomery, a nutritionist based in London, emphasized the need for caution when consuming supplements. "Ashwagandha has been used for thousands of years and is known for its stress-relieving properties," she noted. "However, excessive intake can adversely affect the body and lead to various health issues. It's crucial to establish an upper limit for its inclusion in supplements to ensure proper regulation and consumer safety."
As the investigation progresses, the FSA aims to gather comprehensive data to inform potential regulatory measures and safeguard public health.
